Initial glycine serum level is not a predictor of the recovery resulting from glycine augmentation of antipsychotic treatment
Journal Title: Archives of Psychiatry and Psychotherapy - Year 2011, Vol 13, Issue 2
Abstract
Glycine is a non-competitive NMDA co-agonist of an ionotropic NMDA receptor in the glutamate system. Beneficial effects of this amino acid on primary negative symptoms of schizophrenia were revealed in the literature. The main research hypothesis assumes the existence of a relationship between negative symptoms of schizophrenia and serum glycine concentration. Aim. The aim of the study is finding a relationship between the initial glycine serum concentrations together with changes in concentration of this compound and severity of schizophrenia symptoms (in PANSS) and selected cognitive functions as a result of application of glycine at a dose of 0.8g/kg/day orally added to the existing antipsychotic treatment. Method. A group of 28 individuals with schizophrenia with predominantly negative symptoms completed a 6-week open-label prospective study. The patients received oral glycine (60g/day) in parallel with the existing antipsychotic treatment At the beginning and end of the study serum glycine levels were measured and the severity of the symptomsof schizophrenia using PANSS and cognitive functioning (using Wisconsin Card Sorting Test, Trail Making Test and Stroop Test) were assessed. Results. From the data, obtained on two check-ups before and after the 6 weeks of glycine application, no significant correlations between serum glycine concentrations and either the PANSS score (subscales assessing positive and negative symptoms, general psychopathology and a total score) or the cognitive battery results were found excluding a correlation between the increase in the glycine concentration and the reduction in the number of errors in the second part of the Trail Making Test (TMT). Conclusion. Measurements of serum amino acid concentrations do not allow direct assessment of severity of disease symptoms or resulting improvement. Unfortunately, the initial serum glycine concentration may not be used as a predictor of the improvement resulting from augmentation of antipsychotic treatment with glycine. The results obtained in the whole PANSS scale and in its subscales suggest beneficial effects of glycine in the applied dose on the psychopathology of schizophrenia.
Authors and Affiliations
Dominik Strzelecki, Olga Kałużyńska, Tomasz Pawełczyk, Jolanta Rabe-Jabłońska
Psychological interventions in cardiology - short-term motivational strategies
Cardiovascular diseases are the most important cause of death in industrialized countries. They require long treatment and their prevention is a long-term effort at individual and social levels. Therefore more and more a...
Marital Therapy/Couples Therapy: Indications and Contraindications
The author, basing on literature and her own experiences in conducting marital/couples, presents the indications and contraindications for this form of therapy for both recipients of the therapy and therapists. Insuffici...
Treatment without consent – dialogue, or psychiatric language games?
Aim. The main aim of presented paper is the discussion with the anti-psychiatry’s and postpsychiatry’s critique of psychiatric inpatient wards and their practices. Method and subject. Basing on the story of one patient,...
Reducing stigma of criminal insanity
Summary Aim. Analysis of phenomena and possible factors influencing public opposition to the program of Residential Secure Treatment Facility for criminally insane patients. Method. Review of the minutes of meeting wit...
Characteristics of subjects with self reported history of psychosis who were interested in self-assessment of their functional status via online e-diaries
Aim. To identify a profile of subjects with psychotic symptoms who were interested in self–monitoring of their functional status via an online electronic diary (e-diary). Method. The TacyJakJa.pl website was promoted by...